Feedback / Questions
OpRegen (RG6501) - Lineage Cell Therap, Novartis, Roche
https://www.businesswire.com/news/home/20240116211178/en/RG6501-OpRegen%C2%AE-Phase-12a-Results-Will-Be-Featured-at-2024-Angiogenesis-Exudation-and-Degeneration-Meeting-in-Presentation-by-Allen-Ho-MD-FACS-FASRS
Jan 16, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next